ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.70
+0.61 (2.76%)
Apr 8, 2026, 11:47 AM EDT - Market open
ACADIA Pharmaceuticals Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$30.55
Upside
+34.58%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $29 | Hold → Strong Buy | Upgrades | $29 | +27.75% | Mar 25, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $31 → $34 | Buy | Maintains | $31 → $34 | +49.78% | Mar 4, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $35 → $37 | Strong Buy | Maintains | $35 → $37 | +63.00% | Feb 26, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +32.16% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $34 → $35 | Buy | Maintains | $34 → $35 | +54.19% | Feb 26, 2026 |
| Stifel | Stifel | Hold Maintains $25 → $24 | Hold | Maintains | $25 → $24 | +5.73% | Feb 26, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $33 | Buy | Initiates | $33 | +45.37% | Feb 24, 2026 |
| Mizuho | Mizuho | Hold → Buy Upgrades $29 → $35 | Hold → Buy | Upgrades | $29 → $35 | +54.19% | Feb 23, 2026 |
| Oppenheimer | Oppenheimer | Hold Maintains $21 → $23 | Hold | Maintains | $21 → $23 | +1.32% | Feb 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $31 | Buy | Maintains | $35 → $31 | +36.56% | Feb 3, 2026 |
| Citizens | Citizens | Buy Reiterates $34 | Buy | Reiterates | $34 | +49.78% | Feb 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +63.00% | Feb 3, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $33 → $36 | Strong Buy | Maintains | $33 → $36 | +58.59% | Jan 6, 2026 |
| UBS | UBS | Strong Buy Maintains $35 → $40 | Strong Buy | Maintains | $35 → $40 | +76.21% | Jan 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $37 | Strong Buy | Maintains | $32 → $37 | +63.00% | Dec 15, 2025 |
| Stifel | Stifel | Hold Maintains $24 → $25 | Hold | Maintains | $24 → $25 | +10.13% | Dec 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.